Bakay, Umut, and Tuğba İzci Duran. “Real-World Effectiveness and Safety of Upadacitinib in Tumor Necrosis FactorInhibitor Refractory Axial Spondyloarthritis: 52-Week Outcomes from a Single-Center Cohort”. Archives of Rheumatology 40, no. 4 (December 1, 2025): 465–473. Accessed December 5, 2025. https://www.anadolupsikiyatri.net/index.php/pub/article/view/1520.